Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma-Reference-Cited by-同舟云学术

Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma

Published:2018-04 Issue: Volume:79 Page:9-14
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Barney Christian L.,Walston Steve,Zamora Pedro,Healy Erin H.,Nolan Nicole,Diavolitsis Virginia M.,Neki Anterpreet,Rupert Robert,Savvides Panos,Agrawal Amit,Old Matthew,Ozer Enver,Carrau Ricardo,Kang Stephen,Rocco James,Teknos Theodoros,Grecula John C.,Wobb Jessica,Mitchell Darrion,Blakaj Dukagjin,Bhatt Aashish D.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference25 articles.

1. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site;Blanchard;Radiother Oncol,2011

3. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

4. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

5. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioradiotherapy with Cetuximab May Reduce the Risk of Neck Node Relapse in Locoregionally Advanced Laryngeal Glottic Carcinoma: May HER1-Profile Be Useful in the Bioselection of Patients?;Journal of Personalized Medicine;2022-09-11

2. Treatment de‐escalation for HPV + oropharyngeal cancer: A systematic review and meta‐analysis;Head & Neck;2022-03-03

3. Solid Tumours and Update on Modern Medical Oncology Interventions;Orofacial Supportive Care in Cancer;2022

4. Trimodality therapy for HPV-positive oropharyngeal cancer: A population-based study;Oral Oncology;2019-11

5. Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE;European Archives of Oto-Rhino-Laryngology;2019-03-18